Abstract
Braithwaite and Tsevat discuss a new study that suggests that antiretroviral treatment is indeed cost-effective.
MeSH terms
-
Anti-Retroviral Agents / economics*
-
Anti-Retroviral Agents / therapeutic use
-
Antiretroviral Therapy, Highly Active / economics*
-
Cost-Benefit Analysis
-
HIV Infections / drug therapy
-
HIV Infections / economics*
-
Health Care Rationing
-
Health Policy
-
Humans
-
Public Health
-
South Africa